Ticovac 2.4MCG/0.5 10S
Ended Awarded
- Contract number
- SPE2DX26FKUMJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $6,327
Award facts
- Contract value 100% obligated
- $6,326.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $6,326.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TICOVAC 2.4 MCG/0.5 vaccine product. The delivery order, issued on October 23, 2025, with an ultimate completion date of November 6, 2025, was structured as a firm fixed-price contract with no set-aside designation, allowing the vendor to compete on equal footing in open federal procurement. This delivery order represents one of numerous pharmaceutical supply transactions issued to DMS Pharmaceutical Group through its prime vendor contract vehicle established under the Defense Logistics Agency's broader acquisition strategy.
DMS Pharmaceutical Group Inc. operates as a critical pharmaceutical supplier under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, holding a single-award indefinite delivery contract with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V program, a $30.3 billion acquisition strategy, authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical and medical consumable supplies to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across diverse product categories, including vaccines, biologics, specialty pharmaceuticals, and routine medications, positions the company as a key regional prime vendor contractor within the Department of Defense's global medical supply chain operations.
Quick answers
Who was awarded contract SPE2DX26FKUMJ?
SPE2DX26FKUMJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 23, 2025.
How much is contract SPE2DX26FKUMJ worth?
The government has obligated $6,327 on SPE2DX26FKUMJ.
Is contract SPE2DX26FKUMJ an order under another contract?
Yes. SPE2DX26FKUMJ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX26FKUMJ competed?
The extent of competition for SPE2DX26FKUMJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award